Stockreport

IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership [Yahoo! Finance]

Clene Inc.  (CLNN) 
PDF LOS ANGELES, CA - ( NewMediaWire ) - September 26, 2024 - Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmac [Read more]